GH Research (GHRS) Dividends Paid - Common (2023 - 2025)
GH Research (GHRS) posted quarterly Dividends Paid - Common of -$4.2 million for Q3 2025, down 244.09% year-over-year from $2.9 million in Q3 2024, and down 147.3% quarter-over-quarter from $8.9 million in Q2 2025.
GH Research (GHRS) Dividends Paid - Common (2023 - 2025) Analysis & Trends
GH Research's Dividends Paid - Common history runs 3 years deep, the most recent figure standing at -$4.2 million for Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 96.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 34.60 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | GH Research | 2.02 Bn | 1.68 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -4.22 Mn |
| Sep 30, 2025 | -4.22 Mn |
| Jun 30, 2025 | 8.92 Mn |
| Jun 30, 2025 | 8.92 Mn |
| Mar 31, 2025 | 244.95 Mn |
| Mar 31, 2025 | 244.95 Mn |
| Sep 30, 2024 | 2.93 Mn |
| Sep 30, 2024 | 2.93 Mn |
| Jun 30, 2024 | 9.65 Mn |
| Jun 30, 2024 | 9.65 Mn |
| Mar 31, 2024 | 77.48 Mn |
| Mar 31, 2024 | 77.48 Mn |
| Sep 30, 2023 | -10.46 Mn |
| Sep 30, 2023 | -10.46 Mn |
| Jun 30, 2023 | -8.19 Mn |
| Jun 30, 2023 | -8.19 Mn |
| Mar 31, 2023 | 105.08 Mn |
| Mar 31, 2023 | 105.08 Mn |